Therapeutic Potential of Oligo-Fucoidan in Mitigating Peritoneal Dialysis-Associated Fibrosis
Peritoneal dialysis (PD) serves as a home-based kidney replacement therapy with increasing utilization across the globe. However, long-term use of high-glucose-based PD solution incites repeated peritoneal injury and inevitable peritoneal fibrosis, thus compromising treatment efficacy and resulting...
Saved in:
| Main Authors: | Yu-Wei Chen, Mei-Yi Wu, Nai-Jen Huang, Mai-Szu Wu, Yung-Ho Hsu, Chia-Te Liao, Cheng-Hsien Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Marine Drugs |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1660-3397/22/12/529 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pressure induces peritoneal fibrosis and inflammation through CD44 signaling
by: Yu-Wei Chen, et al.
Published: (2024-12-01) -
Metabolic reprogramming of peritoneal mesothelial cells in peritoneal dialysis–associated fibrosis: therapeutic targets and strategies
by: Fang Yu, et al.
Published: (2025-02-01) -
MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3
by: Nan Li, et al.
Published: (2024-12-01) -
Effect of different dialysis duration on the prognosis of peritoneal dialysis-associated peritonitis: a single-center, retrospective study
by: Qichen Liang, et al.
Published: (2023-12-01) -
Recent advances in the diagnosis and treatment of peritoneal dialysis-associated peritonitis
by: Hou Shi-hui, et al.
Published: (2022-09-01)